Fertility benefits and reproductive health services
Strategic Profile
Kindbody has evolved into a next-generation fertility platform that integrates AI-driven intelligence with a hybrid delivery model — combining its 27 owned clinics and IVF labs with a curated national IVF network and 400+ partner clinics across 113 countries. Kindbody's B2B partnerships with self-insured employers enable direct purchasing of benefits, eliminating costly middlemen, differentiating it in a fragmented market.
Cyborg Score Rationale
Bloomberg reported in September 2025 that Kindbody faced a "financial crisis" and was "hemorrhaging cash" according to internal documents, which conflicts with strong market position and impressive funding. Over the past year, Kindbody saw a 6% decline in headcount, indicating operational challenges despite strategic assets.
Top Insights
As of June 2025, the company operated 27 signature clinics and IVF labs, with 400+ partner clinics across 113 countries, serving 135 employers
CEO David Stern succeeded the prior leadership team in mid-2025, signaling recent strategic leadership transition
The platform encompasses AI-enabled intake and navigation, benefits and out-of-pocket cost transparency, AI-supported scribing, an IVF predictor tool, and a fertility medication portal
Future fundraising opportunities look promising, with the potential for an initial public offering (IPO) once Kindbody becomes EBITDA and cash flow positive
Named Competitors
Carrot Fertility — Fertility and family care platform with egg/sperm/embryo freezing and adoption support
Spring Fertility — Venture-backed fertility clinic network
Progyny — Fertility benefits platform and employer family-building solutions
Maven Clinic — Women's and family health telehealth platform
Recent Developments
(June 2026) Partnership announced with Future Family for innovative financing solutions in fertility care access